文献速递临床试验与 GCP

胃癌全腹腔镜根治性胃切除术后早期经口进食的安全性(SOFTLY):随机对照试验研究方案

Safety of early oral feeding after total laparoscopic radical gastrectomy for gastric cancer (SOFTLY): Study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2019-06-26

SOFTLY为单中心、平行组、非劣效性随机对照试验,计划纳入200例病理诊断胃癌并接受腹腔镜根治性胃切除的患者,按1:1随机分为早期经口进食组(术后第1天清流质)与延迟经口进食组(术后第4天清流质)。主要终点为吻合口漏发生率,参照CLASS-01研究对照组1.9%。该试验旨在评估全腹腔镜根治性胃切除术后早期经口进食的安全性与可行性。

要点

  • 早期经口进食组术后第1天给予清流质,延迟经口进食组术后第4天给予清流质。
  • 主要终点为吻合口漏发生率,参照CLASS-01研究对照组1.9%。
  • SOFTLY为单中心、平行组、非劣效性随机对照试验,计划纳入200例患者。

核心结论

  • 全腹腔镜根治性胃切除术后早期经口进食的安全性与可行性尚未确立,SOFTLY试验将首次在全腹腔镜根治性胃切除患者中比较术后第1天早期经口进食与术后第4天延迟经口进食,为其安全性和可行性提供数据。

研究设计与样本

  • SOFTLY为单中心、平行组、非劣效性随机对照试验,计划纳入200例病理诊断胃癌并接受腹腔镜根治性胃切除的患者,按1:1随机分组。

主要发现

  • 早期经口进食组术后第1天(POD1)接受清流质饮食,延迟经口进食组术后第4天(POD4)接受清流质饮食。
  • 主要终点为吻合口漏发生率,基于CLASS-01研究对照组1.9%。
  • 将记录人口学与病理特征、术前及住院期间总营养与经口营养摄入、一般资料、总血清蛋白、血清白蛋白、血糖和体温,并记录不良事件。
  • 术后瘘(包括吻合口漏)作为主要严重术后不良事件和主要终点记录。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文指出全腹腔镜根治性胃切除术后早期经口进食的安全性与可行性尚未确立,缺乏相关指南与证据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gastric cancer is the third most common cause of cancer-related deaths and has the fifth highest incidence worldwide, especially in eastern Asia, central and Eastern Europe, and South America. Currently, surgery is the only curative treatment for gastric cancer; however, there is an increasing trend toward laparoscopic radical gastrectomy. Early oral feeding (EOF) has been shown to benefit clinical outcomes compared with open gastrectomy under conditions of enhanced recovery after surgery. There are a lack of guidelines and evidence for the safety and feasibility of EOF in patients undergoing laparoscopic radical gastrectomy. Thus, a prospective randomized trial is warranted. METHODS/DESIGN: The EOF after total laparoscopic radical gastrectomy (SOFTLY) study is a single-center, parallel-arm, non-inferiority randomized controlled trial which will enroll 200 patients who are pathologically diagnosed with gastric cancer and undergo laparoscopic radical gastrectomy. The primary endpoint, incidence of anastomotic leakage, is based on 1.9% in the control group in the CLASS-01 study. The patients will be randomized (1:1) into two groups: the EOF group will receive a clear liquid diet on post-operative day 1 (POD1) and the delayed oral feeding (DOF) group will receive a clear liquid diet on post-operative day 4 (POD4). The demographic and pathologic characteristics will be recorded. Total and oral nutritional intake, general data, total serum protein, serum albumin, blood glucose, and temperature will be recorded before surgery and at the time of hospitalization. Adverse events will also be recorded. The occurrence of post-operative fistulas, including anastomotic leakage, will be recorded as the main severe post-operative adverse event and represent the primary endpoint. DISCUSSION: The safety and feasibility of EOF after gastrectomy has not been established. The SOFTLY trial will be the first randomized controlled trial involving total laparoscopic radical gastrectomy, in which the EOF group (POD1) will be compared with the DOF group (POD4). The results of the SOFTLY trial will provide data on the safety and feasibility of EOF after total laparoscopic radical gastrectomy. TRIAL REGISTRATION: Chinese Clinical Trial Registry, ChiCTR-IOR-15007660 . Registered on 28 December 2015. The study has full ethical and institutional approval.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Wang Q, Guo BY, Zhao QC, et al. Safety of early oral feeding after total laparoscopic radical gastrectomy for gastric cancer (SOFTLY): Study protocol for a randomized controlled trial. Trials. 2019. PMID: 31242936. doi:10.1186/s13063-019-3493-2

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。